Quality control guidelines for National Committee for Clinical Laboratory Standards recommended broth macrodilution testing of amphotericin B, fluconazole, and flucytosine
about
Structures of Cryptococcus neoformans Protein Farnesyltransferase Reveal Strategies for Developing Inhibitors That Target Fungal PathogensIn vitro activities of semisynthetic pneumocandin L-733,560 against fluconazole-resistant and -susceptible Candida albicans isolatesActivity of a new triazole, Sch 56592, compared with those of four other antifungal agents tested against clinical isolates of Candida spp. and Saccharomyces cerevisiaeAntifungal susceptibility survey of 2,000 bloodstream Candida isolates in the United States.Determination of antifungal MICs by a rapid susceptibility assay.Effects of antifungal interventions on the outcome of experimental infections with phenotypic switch variants of Cryptococcus neoformans.Evaluation of the Etest method for determining fluconazole susceptibilities of 402 clinical yeast isolates by using three different agar media.Optimizing the correlation between results of testing in vitro and therapeutic outcome in vivo for fluconazole by testing critical isolates in a murine model of invasive candidiasisGranulocyte colony-stimulating factor and azole antifungal therapy in murine aspergillosis: role of immune suppressionIn vitro activity of a new polyene, SPA-S-843, against yeasts.Synthesis, characterization, and in vitro activity against Candida spp. of fluconazole encapsulated on cationic and conventional nanoparticles of poly(lactic-co-glycolic acid)Preliminary evaluation of a semisolid agar antifungal susceptibility test for yeasts and molds.Quality control limits for broth microdilution susceptibility tests of ten antifungal agents.Elevated phenotypic switching and drug resistance of Candida albicans from human immunodeficiency virus-positive individuals prior to first thrush episodeFluconazole disk diffusion test with methylene blue- and glucose-enriched Mueller-Hinton agar for determining susceptibility of Candida speciesIn vitro activity of nystatin compared with those of liposomal nystatin, amphotericin B, and fluconazole against clinical Candida isolatesProficiency testing program for clinical laboratories performing antifungal susceptibility testing of pathogenic yeast species.Comparison of Etest and National Committee for Clinical Laboratory Standards broth macrodilution method for antifungal susceptibility testing: enhanced ability to detect amphotericin B-resistant Candida isolatesComparison of a spectrophotometric microdilution method with RPMI-2% glucose with the National Committee for Clinical Laboratory Standards reference macrodilution method M27-P for in vitro susceptibility testing of amphotericin B, flucytosine, and fIn vitro susceptibilities of clinical yeast isolates to a new echinocandin derivative, LY303366, and other antifungal agents.Modified agar dilution susceptibility testing method for determining in vitro activities of antifungal agents, including azole compoundsInterlaboratory study of quality control isolates for a broth microdilution method (modified CLSI M38-A) for testing susceptibilities of dermatophytes to antifungalsAntifungal susceptibility of clinical and environmental Cryptococcus neoformans and Cryptococcus gattii isolates in Jabalpur, a city of Madhya Pradesh in Central India.Comparison of visual and spectrophotometric methods of MIC endpoint determinations by using broth microdilution methods to test five antifungal agents, including the new triazole D0870.Comparison of two alternative microdilution procedures with the National Committee for Clinical Laboratory Standards reference macrodilution method M27-P for in vitro testing of fluconazole-resistant and -susceptible isolates of Candida albicans.Susceptibility testing of fungi: current status of correlation of in vitro data with clinical outcome.Quality control guidelines for National Committee for Clinical Laboratory Standards--recommended broth macrodilution testing of ketoconazole and itraconazoleFluconazole and amphotericin B antifungal susceptibility testing by National Committee for Clinical Laboratory Standards broth macrodilution method compared with E-test and semiautomated broth microdilution testInterlaboratory evaluation of Etest method for testing antifungal susceptibilities of pathogenic yeasts to five antifungal agents by using Casitone agar and solidified RPMI 1640 medium with 2% glucoseMultisite reproducibility of the Etest MIC method for antifungal susceptibility testing of yeast isolates.Strain variation among and antifungal susceptibilities of isolates of Candida krusei.Fluconazole disk diffusion procedure for determining susceptibility of Candida species.Rapid susceptibility testing of fungi by flow cytometry using vital staining.Multicenter evaluation of proposed standardized procedure for antifungal susceptibility testing of filamentous fungi.Lot-to-lot variability of antibiotic medium 3 used for testing susceptibility of Candida isolates to amphotericin B.Superantigen-like effects of a Candida albicans polypeptideSusceptibility testing of fluconazole by the NCCLS broth macrodilution method, E-test, and disk diffusion for application in the routine laboratory.Molecular epidemiology of clinical Cryptococcus neoformans strains from India.Susceptibility of Candida species to photodynamic effects of photofrin.Sensititre YeastOne caspofungin susceptibility testing of Candida clinical isolates: correlation with results of NCCLS M27-A2 multicenter study.
P2860
Q27671538-EF5303C3-B878-48F4-8042-477D367D3156Q28378977-42E468DD-35AE-4400-A6A4-0D1635BFEDBEQ28379453-ED2A3E7C-C156-406C-9A41-1195FC5AC33FQ30452376-F46BE5A8-3C76-4B69-A82C-8EE5A5754046Q30453809-EFB205CE-A311-4052-AC29-0F1CE8381573Q33556039-187C0C08-C131-47B4-B388-ABCC45C32B12Q33682433-59A4CDD2-3B03-4DD6-B5C9-DE1EE5A44BECQ33690616-28E1C3B9-D366-4F7D-9B46-1257494E855DQ33697679-09576101-632F-4876-A2D4-86C7D51B48BDQ33702041-8761C0F7-4675-480D-8650-88435E323487Q33719218-56D96C88-A21A-4D08-874B-18E74F49B752Q33965280-6E5D3249-3EC5-4426-A052-9E6DB4B404E5Q33969748-E4E98E10-0FE7-433E-86DF-176B01D5E4A6Q33969896-4BB767CD-ECD7-4B3C-B417-D3DA5CD93B8CQ33972054-D6175BCD-163E-44F9-AA2D-2FCAB16A2412Q34452652-38E4F807-9E22-49A2-9671-AE18990B941FQ34774346-180D7C74-ECFE-4FE9-BBAD-48A1FF26C918Q35120311-7BE8FEA7-1320-4E4E-87E6-D71106D5CD96Q35126493-FC4643A5-A47D-4D39-802B-7A6FF220265AQ35134781-854B997C-9689-4D18-AEE2-307A2DF76F32Q35136757-2FC1E23F-CFE3-4D95-8984-B33C86842331Q35221125-49DBD428-9684-40D8-B986-01C21BC471C5Q36440166-09C56960-01D8-4662-9AC2-4AAE13A05114Q36521532-B357F995-698E-4E63-AA9C-C0B7478549E9Q36526361-1C0F11CF-8EA8-4A8C-8973-CF1C75954EE8Q36528018-00A0EAE6-027F-47A8-8867-C6A5D61A88E9Q36529693-5319F896-74D3-4B4A-A5C0-8E1DBB31F913Q36529902-C76404C7-F848-4BA4-AAAF-D214F60813CDQ36529935-E5555639-B0C0-473B-89C1-82A77CD0EF1BQ36534987-78CB52A8-47BC-4900-98D4-F345FC00F158Q36536418-8ED690F0-623F-4167-A53F-6C7894DECB6EQ36537557-F8285B8D-DF27-401E-A6D8-ACA793333605Q36542368-96476BDB-22C3-42B2-9376-D8973AC1C247Q36542562-50C8F2FD-885B-456E-A75F-40D2D40986CFQ36542830-73A23210-12D2-41DD-A503-43B416E7917BQ36691784-FB29E6B6-072E-4C5A-9511-EF7B263FB162Q39626581-F016B190-0382-4BBE-979B-0445E440AB22Q39803868-B37F453B-8396-4291-8875-770CD2CFD35DQ40882683-264794AD-3DB2-48D2-909F-123CFA0D81B2Q42051327-36625D97-9935-41BD-9A3E-6844A2E107B5
P2860
Quality control guidelines for National Committee for Clinical Laboratory Standards recommended broth macrodilution testing of amphotericin B, fluconazole, and flucytosine
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Quality control guidelines for ...... , fluconazole, and flucytosine
@ast
Quality control guidelines for ...... , fluconazole, and flucytosine
@en
type
label
Quality control guidelines for ...... , fluconazole, and flucytosine
@ast
Quality control guidelines for ...... , fluconazole, and flucytosine
@en
prefLabel
Quality control guidelines for ...... , fluconazole, and flucytosine
@ast
Quality control guidelines for ...... , fluconazole, and flucytosine
@en
P2093
P2860
P1476
Quality control guidelines for ...... , fluconazole, and flucytosine
@en
P2093
Buschelman B
Espinel-Ingroff A
Lancaster M
McGinnis MR
Pfaller MA
Rinaldi MG
P2860
P304
P407
P50
P577
1995-05-01T00:00:00Z